Abridge's $5.3BN Secret: "Taste Good Things to Have Good Taste
Abridge CEO Shiv Rao reveals how his company's core value drives continuous learning, cultural edge, and $5.3BN AI product success.
40 hours of podcasts, in 5 minutes.
Harry Stebbings interviews Shiv Rao, founder and CEO of Abridge, about the company's journey from a five-year "wilderness" to a $5.3BN valuation in vertical AI for healthcare. They discuss critical lessons on market timing, fundraising, unique company values, navigating the complex healthcare enterprise market, and Abridge's strategy for building proprietary AI models alongside leveraging frontier technology. Rao also shares insights on leadership, talent acquisition, and balancing a demanding founder role with family life.
Abridge CEO Shiv Rao reveals how his company's core value drives continuous learning, cultural edge, and $5.3BN AI product success.
Abridge founder Shiv Rao waited 5 years for AI's market to open up. Here's how he kept his company alive, stayed focused on a 'true north' thesis, and built a $5.3BN giant.
Shiv Rao reveals how Abridge built 40% of its AI models in-house for blazing speed in healthcare workflows, blending bespoke tech with frontier AI.
Abridge CEO Shiv Rao reveals his unconventional strategy for finding early-stage investor fit: 'stalking' Union Square Ventures for years to find intellectual chemistry.
Shiv Rao built Abridge to $5.3BN by eschewing data sales, embedding engineers, and chasing the 'flow of money.' Learn his counter-intuitive healthcare AI strategy.
Abridge CEO Shiv Rao reveals why healthcare founders must ditch the "down market" trap and time their "yolo shot" to enterprise, seizing rare market shifts.
Abridge CEO Shiv Rao shares how "high judgment executives," "tours of duty," and his PPG framework help navigate a $5.3BN AI startup with intense personal trade-offs.